Panacea Index Logo

Command Palette

Search for a command to run...

Efficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant Cancer Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Nutrients
January 1, 1970
Ya-Feng Yang et al. (8 authors)
Journal ArticleMeta-AnalysisSystematic ReviewHuman Study
Study Details

Study Goal

The researchers aimed to investigate the efficacy of a low-carbohydrate ketogenic diet (LCKD) as an adjuvant therapy in antitumor treatment compared to non-ketogenic diets, focusing on lipid profile, body weight, fasting glucose, insulin, and adverse effects.

Results Summary

The study conducted a meta-analysis of RCTs but did not provide specific findings in the abstract regarding the efficacy of LCKD in antitumor treatment or its effects on the measured parameters.

Population

Cancer participants in randomized controlled trials.

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
low-carbohydrate ketogenic diet (LCKD)
neutral
lipid profile
cancer participants
-
investigate the efficacy
#1
low-carbohydrate ketogenic diet (LCKD)
neutral
body weight
cancer participants
-
investigate the efficacy
#2
low-carbohydrate ketogenic diet (LCKD)
neutral
fasting glucose level
cancer participants
-
investigate the efficacy
#3
low-carbohydrate ketogenic diet (LCKD)
neutral
insulin
cancer participants
-
investigate the efficacy
#4
low-carbohydrate ketogenic diet (LCKD)
neutral
adverse effects
cancer participants
-
investigate the efficacy
#5
Abstract

The role of low-carbohydrate ketogenic diet (LCKD) as an adjuvant therapy in antitumor treatment is not well established. This systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted to investigate the efficacy of LCKD as an adjuvant therapy in antitumor treatment compared to non-ketogenic diet in terms of lipid profile, body weight, fasting glucose level, insulin, and adverse effects; Methods: In this study, databases such as PubMed, Web of Science, Scopus, CINAHL, and Cochrane trials were searched. Only RCTs that involved cancer participants that were assigned to dietary interventions including a LCKD group and a control group (any non-ketogenic dietary intervention) were selected. Three reviewers independently extracted the data, and the meta-analysis was performed using a fixed effects model or random effects model depending on the I

Medical Subject Headings (MeSH)
Biomarkers, TumorBlood GlucoseBody WeightCase-Control StudiesDiet, Carbohydrate-RestrictedDiet, KetogenicFastingHumansInsulinLipidsNeoplasmsOdds RatioPatient SatisfactionRandomized Controlled Trials as TopicTreatment Outcome
Study Links
Quality Scores
SafetyNot Assessed
Efficacy65/10
Quality80/10
Citation Metrics
Total Citations31
Citations/Year7.8
Relative Citation Ratio2.47
NIH Percentile80.4%
Research Impact Scores
APT Score0.95
Weight Score1.80
Normalized Score0.62
Related Supplements
Efficacy of Low-Carbohydrate Ketogenic Diet as an Adjuvant C... | Panacea Index